Sale!

Liquid Biopsy Cell-Free KRAS Test

Original price was: $600.Current price is: $450.

-25%

The Liquid Biopsy Cell-Free KRAS Test is a revolutionary non-invasive diagnostic tool that detects KRAS mutations in circulating tumor DNA from blood samples. This advanced test utilizes Droplet Digital PCR technology to identify specific genetic alterations associated with various cancers, including colorectal, pancreatic, and lung cancers. By analyzing cell-free DNA fragments released by tumors into the bloodstream, the test provides crucial information for cancer diagnosis, treatment selection, and monitoring. The test is particularly valuable for patients who cannot undergo traditional tissue biopsies or need regular monitoring. Results are typically available within 5-7 days, and the test requires only a simple blood draw using Streck tubes. At just $450 (regularly $600), this test offers an accessible option for comprehensive cancer genetic screening and personalized treatment planning.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

Liquid Biopsy Cell-Free KRAS Test

Revolutionary Non-Invasive Cancer Detection

The Liquid Biopsy Cell-Free KRAS Test represents a groundbreaking advancement in cancer diagnostics, offering a minimally invasive alternative to traditional tissue biopsies. This innovative test analyzes circulating tumor DNA (ctDNA) present in peripheral blood samples to detect KRAS gene mutations, which play a critical role in cancer development and progression. By harnessing the power of Droplet Digital PCR technology, our test provides highly sensitive and specific detection of genetic alterations that drive tumor growth.

What Does the Test Measure?

The Liquid Biopsy Cell-Free KRAS Test specifically identifies mutations in the KRAS (Kirsten rat sarcoma viral oncogene homolog) gene, including:

  • KRAS G12D, G12V, G12C, G13D mutations
  • Other common KRAS codon 12 and 13 mutations
  • Mutation frequency and variant allele fraction
  • Presence of circulating tumor DNA in blood

Who Should Consider This Test?

This test is particularly beneficial for individuals experiencing:

  • Patients with suspected or diagnosed colorectal cancer
  • Individuals with pancreatic cancer symptoms or diagnosis
  • Patients with non-small cell lung cancer
  • Those requiring treatment response monitoring
  • Patients unable to undergo traditional tissue biopsy
  • Individuals seeking early cancer detection and screening
  • Patients with family history of KRAS-associated cancers

Key Benefits of Liquid Biopsy KRAS Testing

  • Non-Invasive Procedure: Simple blood draw eliminates need for surgical biopsy
  • Early Detection Capability: Identifies cancer-associated mutations before symptoms appear
  • Treatment Guidance: Helps determine appropriate targeted therapies
  • Monitoring Tool: Tracks treatment response and disease progression
  • Minimal Discomfort: Blood collection is quick and virtually painless
  • Rapid Results: Turnaround time of 5-7 days for prompt decision-making

Understanding Your Test Results

Your Liquid Biopsy Cell-Free KRAS Test results will provide valuable insights into your genetic profile:

Positive Result Interpretation

A positive result indicates the presence of KRAS mutations in circulating tumor DNA. This finding may suggest:

  • Active cancer presence requiring further evaluation
  • Need for specific treatment approaches based on mutation type
  • Potential resistance to certain targeted therapies
  • Requirement for ongoing monitoring and follow-up testing

Negative Result Interpretation

A negative result suggests no detectable KRAS mutations were found, which may indicate:

  • Lower likelihood of KRAS-driven cancers
  • Potential eligibility for EGFR-targeted therapies
  • Need for continued monitoring if clinical suspicion remains
  • Possibility of other genetic alterations driving cancer

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $450
Regular Price $600

Important Pre-Test Information

The Liquid Biopsy Cell-Free KRAS Test requires a doctor’s prescription for most cases. Prescription requirements do not apply for surgical planning, pregnancy-related testing, or international travel medical clearance. Sample collection utilizes specialized Streck tubes to ensure sample stability and integrity during transport and processing.

Nationwide Availability

GGC DNA has testing facilities conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures accessible testing options for patients nationwide.

Take Action for Your Health Today

Don’t wait to gain critical insights into your cancer risk and treatment options. The Liquid Biopsy Cell-Free KRAS Test provides comprehensive genetic information that can guide your healthcare decisions and potentially save lives through early detection.

Book your test now by calling our dedicated healthcare line at +1(267) 388-9828 or schedule your appointment online. Our genetic counselors are available to answer your questions and help you understand the testing process.

Take control of your health with advanced genetic testing technology from GGC DNA – your trusted partner in precision medicine and cancer diagnostics.